© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
November 17, 2008
Patients with new-onset diabetes mellitus in the VALUE (Valsartan Antihypertensive Long-term Use Evaluation) trial had an increased incidence of atrial fibrillation compared with patients without diabetes. Clustering of risk factors or the presence of dysglycemia may make the heart more susceptible to arrhythmias.
Simulation Software Could Improve Teenage ADHD Driver Safety
Local Approach Needed to Increase Hepatitis B Vaccinations in Indonesia
Study Finds Increased Risk of Psoriasis for Patients with Herpes Zoster